Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

BMRN – biomarin pharmaceutical inc. (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BMRN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/4
09:36 am
bmrn
Rating for BMRN
Low Report
Rating for BMRN
Report
3/4
09:36 am
bmrn
Rating for BMRN
Low Report
Rating for BMRN
Report
3/3
07:18 am
bmrn
BioMarin Pharmaceutical (BMRN) had its "overweight" rating reaffirmed by Barclays PLC.
Low Report
BioMarin Pharmaceutical (BMRN) had its "overweight" rating reaffirmed by Barclays PLC.
Report
2/26
02:51 pm
bmrn
Rating for BMRN
Low Report
Rating for BMRN
Report
2/25
11:59 am
bmrn
Rating for BMRN
Low Report
Rating for BMRN
Report
2/25
11:59 am
bmrn
Rating for BMRN
Low Report
Rating for BMRN
Report
2/25
09:18 am
bmrn
Rating for BMRN
Low Report
Rating for BMRN
Report
2/25
09:18 am
bmrn
Rating for BMRN
Low Report
Rating for BMRN
Report
2/24
09:24 am
bmrn
Rating for BMRN
Low Report
Rating for BMRN
Report
2/24
09:24 am
bmrn
Rating for BMRN
Low Report
Rating for BMRN
Report
2/18
09:12 am
bmrn
Rating for BMRN
Medium Report
Rating for BMRN
Report
2/18
09:12 am
bmrn
Rating for BMRN
Medium Report
Rating for BMRN
Report
1/28
08:03 am
bmrn
BioMarin Pharmaceutical (NASDAQ:BMRN) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $80.00 price target on the stock.
Low Report
BioMarin Pharmaceutical (NASDAQ:BMRN) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $80.00 price target on the stock.
Report
1/20
07:55 am
bmrn
Rating for BMRN
Medium Report
Rating for BMRN
Report
1/20
05:05 am
bmrn
BioMarin upgraded to Buy from Hold at Canaccord
Low Report
BioMarin upgraded to Buy from Hold at Canaccord
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2026, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0